Wormington & Bollinger: AbbVie, Inc.’s Zymaxid ™ Implicated in Product Liability Lawsuit Due to Risk of Serious Injury and Death

AbbVie faces lawsuit over Zymaxid™. MCKINNEY, Texas, July 2, 2024 /PRNewswire-PRWeb/ — Wormington & Bollinger is actively reviewing product liability cases associated with antibiotic eyedrops causing Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). AbbVie, Inc. (NYSE:…

Go to Source